Company Profiles

driven by the PitchBook Platform

EpiVax

Description

Operator of a biotechnology company focused on the development of vaccines and immunotherapies. The company engages in the development and implementation of computational immunology tools for treatment of smallpox, AIDS, tuberculosis, Type I diabetes, cancer and other diseases.

1998

Founded

PRIVATE

Status

11-50

Employees

Grant

Latest Deal Type

$600k

Latest Deal Amount

2

Investors

Description

Operator of a biotechnology company focused on the development of vaccines and immunotherapies. The company engages in the development and implementation of computational immunology tools for treatment of smallpox, AIDS, tuberculosis, Type I diabetes, cancer and other diseases.

Website:

www.epivax.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery

Primary Office

146 Clifford Street Providence, RI 02903United States +1 (401) 272-2123
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore EpiVax's full profile, request a free trial.

EpiVax Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

EpiVax Investors (2)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
National Institutes of HealthGovernment000 0000000 0000
Slater Technology FundVenture CapitalMinority000 0000000 0000
National Institutes of Health Government
Slater Technology Fund Venture Capital

EpiVax Executive Team (4)

NameTitleBoard
Seat
Contact
Info
Anne De Groot MDChief Executive Officer, Director, Co-Founder & Chief Scientific Officer
William MartinCo-Founder, Chief Information Officer & Chief Operating Officer
Clifford GrimmManaging Director
Lenny Moise Ph.DScientific Director, Vaccine Research
Anne De Groot MD Chief Executive Officer, Director, Co-Founder & Chief Scientific Officer
William Martin Co-Founder, Chief Information Officer & Chief Operating Officer
Clifford Grimm Managing Director
Lenny Moise Ph.D Scientific Director, Vaccine Research
Request full access to PitchBook